Showing results (291-300 of 991) with videos related to
Sort By:
Pageof 100
Cardiology in Review|February 18, 2026
The Alpha-Gal Syndrome and Hypersensitivity to Biomaterials: Understanding XenoimmunityNabeel Sami, Manish A Parikh, Nino Mihatov, et al.Arxiv|June 3, 2024
Fully Automated Construction of Three-dimensional Finite Element Simulations from Optical Coherence TomographyRoss Straughan, Karim Kadry, Sahil A Parikh, et al.Cardiology in Review|January 3, 2025
Iloprost: Old and New IndicationsBrinda Banerji, Manish A Parikh, Ruth Minkin, et al.Cardiology Clinics|November 10, 2023
Nonhyperemic Pressure Ratios-All the Same or Nuanced Differences?Samineh Sehatbakhsh, Weijia Li, Tatsunori Takahashi, et al.JCO Oncology Practice|October 16, 2023
Racial Differences in Patient-Reported Access to Telehealth: An Important and Unmeasured Social Determinant of HealthJohn A Iasiello, Arvind Rajan, Emmanuel Zervos, et al.Blood|February 5, 2016
Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysisSameer A Parikh, Paolo Strati, Mazie Tsang, et al.The Journal of Surgical Research|January 11, 2025
Clinical and Demographic Factors Associated Suicide Risk in Patients With Colorectal CancerAnnmarie Butare, M Drew Honaker, Sydney Taylor, et al.Interventional Cardiology Clinics|November 13, 2022
Nonhyperemic Pressure Ratios-All the Same or Nuanced Differences?Samineh Sehatbakhsh, Weijia Li, Tatsunori Takahashi, et al.Journal of Surgical Oncology|May 10, 2014
The effect of health insurance status on the treatment and outcomes of patients with colorectal cancerAlexander A Parikh, Jamie Robinson, Victor M Zaydfudim, et al.Oncotargets and Therapy|June 25, 2014
The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatmentRahul A Parikh, Peng Wang, Jan H Beumer, et al.Pageof 100